CompletedNot Applicable

Cost-effectiveness of Reduction Mammaplasty

Brazil50 participantsStarted 2008-07

Plain-language summary

Several works show breast hypertrophy as pain cause, postural alterations, dermatitis and decrease of the functional capacity and of the self-esteem. The economical evaluations are destined to esteem the costs in alternative ways of attendance to the health, comparing, for instance, clinical strategies with surgical strategies. OBJECTIVE: To analyze cost-effectiveness in reduction mammaplasty.

Who can participate

Age range18 Years – 59 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Women with breast hypertrophy according to the Sacchini index Exclusion Criteria: * Pregnant women * Patients who gave birth or were breastfeeding less than one year before the beginning of the study * Patients with uncontrolled systemic diseases, acute diseases, or breast asymmetry * Patients who had undergone breast or spine surgery * Patients who had body-mass index (BMI) lower than 18.5 kg/m2 (low body weight) or greater than 30 kg/m2 (obese women)

What they're measuring

The total cost for procedure will be calculated with accuracy through the Brazilian software "TASY". To evaluate the effectiveness will be used the SHORT FORM 36, Visual Analogue Scale, Stanford Health Assessment Questionnaire 20 and SHORT FORM-6D

Timeframe: before the surgery (baseline)

Timeframe: 3 months after surgery

Timeframe: 6 months after the surgery

Trial details

NCT IDNCT00992368

SponsorFederal University of São Paulo

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2009-12

View on ClinicalTrials.gov More Breast,Hypertrophy trials